Item 2. Properties
2K characters. Original on sec.gov · Markdown
Item 2. Properties
Medtronic's principal executive office is located in Ireland and is leased by the Company, while its main operational offices are located in the Minneapolis, Minnesota metropolitan area and are owned by the Company.
The Company's total manufacturing and research space is approximately 9.6 million square feet. Approximately 35 percent of the manufacturing or research facilities are owned by Medtronic and the balance is leased. The following is a summary of the Company's largest manufacturing and research facilities by location:
| Location Country or State | Square Feet (in thousands) | |||||||
| Connecticut | 1,138 | |||||||
| Puerto Rico | 811 | |||||||
| Mexico | 762 | |||||||
| China | 735 | |||||||
| Minnesota | 623 | |||||||
| Italy | 454 | |||||||
| Ireland | 446 | |||||||
| Dominican Republic | 304 | |||||||
| Arizona | 294 | |||||||
| Switzerland | 283 | |||||||
| France | 270 | |||||||
| Colorado | 259 | |||||||
| California | 204 |
Medtronic also maintains sales and administrative offices in the U.S. at six locations in six states and outside the U.S. at 138 locations in 63 countries. Most of these locations are leased. The Company is using substantially all of its currently available productive space to develop, manufacture, and market its products. The Company's facilities are well-maintained, suitable for their respective uses, and adequate for current needs.
Previous: Item 1B. Unresolved Staff Comments · Next: Item 3. Legal Proceedings